Kyntra Bio, Inc. (KYNB)
NASDAQ: KYNB · Real-Time Price · USD
6.79
+0.01 (0.15%)
At close: Jul 30, 2026, 4:00 PM EDT
7.13
+0.34 (4.97%)
After-hours: Jul 30, 2026, 6:23 PM EDT
Kyntra Bio Market Cap
Kyntra Bio has a market cap or net worth of $27.49 million as of July 30, 2026. Its market cap has decreased by -5.22% in one year.
Market Cap
27.49M
Enterprise Value
-40.50M
1-Year Change
-5.22%
Ranking
Category
Stock Price
$6.79
ChartMarket Cap Chart
Since November 14, 2014, Kyntra Bio's market cap has decreased from $1.22B to $27.49M, a decrease of -97.76%. That is a compound annual growth rate of -27.68%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 30, 2026 | 27.49M | -22.57% |
| Dec 31, 2025 | 35.50M | -33.52% |
| Dec 31, 2024 | 53.40M | -38.76% |
| Dec 29, 2023 | 87.20M | -94.21% |
| Dec 30, 2022 | 1.51B | 15.15% |
| Dec 31, 2021 | 1.31B | -61.28% |
| Dec 31, 2020 | 3.38B | -9.80% |
| Dec 31, 2019 | 3.74B | -4.85% |
| Dec 31, 2018 | 3.93B | 1.17% |
| Dec 29, 2017 | 3.89B | 187.60% |
| Dec 30, 2016 | 1.35B | -27.68% |
| Dec 31, 2015 | 1.87B | 22.78% |
| Dec 31, 2014 | 1.52B | 24.27% |
| Nov 14, 2014 | 1.22B | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lantern Pharma | 33.17M |
| Lite Strategy | 33.00M |
| Estrella Immunopharma | 32.21M |
| BriaCell Therapeutics | 31.07M |
| Serina Therapeutics | 31.04M |
| Actinium Pharmaceuticals | 27.19M |
| ABVC BioPharma | 26.79M |
| Aligos Therapeutics | 26.30M |